Janaki M. Subramanyam, MSc, RAC
Vice President, Head of Regulatory Affairs
Janaki (Jana) Subramanyam is Vice President, Head of Regulatory Affairs at Climb Bio. She is an experienced regulatory affairs professional for both drugs and biologic development programs in small to mid-size biotechnology companies. Jana’s experience spans multiple therapeutic areas including nephrology, rheumatology, neurology, psychiatry, hematology, oncology, cardiology and medical imaging products. Her leadership experience in regulatory drug development includes nonclinical, manufacturing and quality, as well as clinical development, pharmacology, regulatory development and post marketing advertising and promotional expertise. Prior to joining Climb Bio, Jana was Vice President, Head of Regulatory Affairs at Abcuro, Inc. where she helped develop Ulviprubart, a humanized afucosylated monoclonal antibody for autoimmune disorders & rare cancers. Jana also held leadership roles in Regulatory Affairs at Abcuro Inc., Allena Pharmaceuticals, FORUM Pharmaceuticals, Lantheus Medical Imaging & AMAG Pharmaceuticals.
Ms. Subramanyam received her MSc in Microbiology from Ohio University and her BSc in Microbiology & Biochemistry from Bombay University.
Developing innovative treatments for our patients to help us climb to a better future.